Happy share that our cross-sectional study "Patients’ disease burden, satisfaction, and use of technology in rheumatoid arthritis (RA) in Greece" was presented last week, at the PanHellenic Conference on Health Economics & Policies 2023. The study was carried out...
Delighted to have been part of ISPOR—The Professional Society for Health Economics and Outcomes Research in #copenhagen ! Presenting 10 #posters was a highlight, especially with one making it to the top 5%. 🏆 Once again, it was an excellent #ISPOREurope! Thanks to all...
We are excited to announce that Health Through Evidence will be participating in the upcoming ISPOR – International Society for Pharmaceutical Outcomes Research – Europe 2023 conference, to be held in Copenhagen between November 13th and 15th. Health Through Evidence...
Happy to share our latest publication " Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece". Happy to share our most recent, open-access publication " Health and...
Happy to share our latest publication about the potential health and economic impact of switching the current 13-valent Pneumococcal Conjugate Vaccine (PCV13) among the Greek paediatric Vaccination programme with higher-valent conjugate vaccines. Find out more at:...